Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Lymphoma, Follicular 1Leukemia, Hairy Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Burkitt Lymphoma 1Anus Neoplasms 1

Interventions

Oxaliplatin 11Fluorouracil 10Capecitabine 9Leucovorin 7Radiotherapy 6Nivolumab 6Cetuximab 5Magnetic Resonance Spectroscopy 4Specimen Handling 3Radiation 3Bevacizumab 3sintilimab 2pembrolizumab 2fludarabine 2encorafenib 2dostarlimab 2aldesleukin 2Trastuzumab 2Tomography, X-Ray Computed 2Surveys and Questionnaires 2Surgical Procedures, Operative 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Pemetrexed 2Magnetic Resonance Imaging 2Irinotecan 2Gemcitabine 2Folfox protocol 2Endoscopy 2Electrocardiography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Diphenhydramine × 30 days × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡